Monitoring microRNAs Using a Molecular Beacon in CD133+/CD338+ Human Lung Adenocarcinoma-initiating A549 Cells |
Yao, Quan
(Diagnosis and Treatment Center of Cancer, Chengdu Military General Hospital)
Sun, Jian-Guo (Institute of Cancer, Xinqiao Hospital, Third Military Medical University) Ma, Hu (Department of Oncology, Affiliated Hospital of Zunyi Medical University) Zhang, An-Mei (Institute of Cancer, Xinqiao Hospital, Third Military Medical University) Lin, Sheng (Department of Oncology, Affiliated Hospital of Luzhou Medical College) Zhu, Cong-Hui (Institute of Cancer, Xinqiao Hospital, Third Military Medical University) Zhang, Tao (Diagnosis and Treatment Center of Cancer, Chengdu Military General Hospital) Chen, Zheng-Tang (Institute of Cancer, Xinqiao Hospital, Third Military Medical University) |
1 | Zhou S, Schuetz JD, Bunting KD, et al (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the sidepopulation phenotype. Nat Med, 7, 1028-34. DOI ScienceOn |
2 | Wu K, Ding J, Chen C, et al (2012). Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology, 56, 2255-67. DOI |
3 | Tyagi S, Kramer FR (1996). Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol, 14, 303-8. DOI ScienceOn |
4 | Wang B, Majumder S, Nuovo G, et al (2009a). Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology, 50, 1152-61. DOI |
5 | Wang QZ, Xu W, Habib N, Xu R (2009b). Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets, 9, 572-94. DOI ScienceOn |
6 | Xie Y, Todd NW, Liu Z, et al (2010). Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer, 67, 170-6. DOI |
7 | Yanaihara N, Caplen N, Bowman E, et al (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-98. DOI ScienceOn |
8 | Yao Q, Zhang AM, Ma H, et al (2012). Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer. Mol Cell Probes, 26, 182-7. DOI |
9 | Yin S, Li J, Hu C, et al (2007). CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer, 120, 1444-50. DOI |
10 | Yu F, Deng H, Yao H, et al (2010). Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene, 29, 4194-204. DOI ScienceOn |
11 | Yu F, Jiao Y, Zhu Y, et al (2012). MicroRNA 34c gene downregulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J Biol Chem, 287, 465-73. DOI |
12 | Meng X, Li M, Wang X, Wang Y, Ma D (2009). Both CD133+ and CD133-subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci, 100, 1040-6. DOI ScienceOn |
13 | O'Brien CA, Pollett A, Gallinger S, Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-10. DOI ScienceOn |
14 | Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al (2007). Identification and expansion of human colon-cancerinitiating cells. Nature, 445, 111-5. DOI ScienceOn |
15 | Santangelo P, Nitin N, Bao G (2006). Nanostructured probes for RNA detection in living cells. Ann Biomed Eng, 34, 39-50. DOI |
16 | Seo DC, Sung JM, Cho HJ, et al (2007). Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer, 6, 75. DOI |
17 | Singh SK, Clarke ID, Terasaki M, et al (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res, 63, 5821-8. |
18 | Singh SK, Hawkins C, Clarke ID, et al (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401. DOI ScienceOn |
19 | Suetsugu A, Nagaki M, Aoki H, et al (2006). Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/ progenitor cells. Biochem Biophys Res Commun, 351, 820-824. DOI ScienceOn |
20 | Sullivan JP, Minna JD, Shay JW (2010). Evidence for selfrenewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev, 29, 61-72. DOI |
21 | Tyagi S, Bratu DP, Kramer FR (1998). Multicolor molecular beacons for allele discrimination. Nat Biotechnol, 16, 49-53. DOI ScienceOn |
22 | Ho MM, Ng AV, Lam S, Hung JY (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res, 67, 4827-33. DOI ScienceOn |
23 | Jemal A, Siegel R, Ward E, et al (2006). Cancer statistics, 2006. CA Cancer J Clin, 56, 106-30. DOI ScienceOn |
24 | Henschke CI, Yankelevitz DF, Libby DM, et al (2006). Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med, 355, 1763-71. DOI ScienceOn |
25 | Hermann PC, Huber SL, Herrler T, et al (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1, 313-23. DOI ScienceOn |
26 | Jiang S, Zhang HW, Lu MH, et al (2010). MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res, 70, 3119-27. DOI ScienceOn |
27 | Juan D, Alexe G, Antes T, et al (2010). Identification of a microRNA panel for clear-cell kidney cancer. Urology, 75, 835-41. DOI |
28 | Kim Y, Yang CJ, Tan W (2007). Superior structure stability and selectivity of hairpin nucleic acid probes with an L-DNA stem. Nucleic Acids Res, 35, 7279-87. DOI |
29 | Kong W, He L, Coppola M, et al (2010). MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem, 285, 17869-79. DOI ScienceOn |
30 | Krol J, Loedige I, Filipowicz W (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet, 11, 597-610. |
31 | Kwak PB, Iwasaki S, Tomari Y (2010). The microRNA pathway and cancer. Cancer Sci, 101, 2309-15. DOI |
32 | Eramo A, Lotti F, Sette G, et al (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ, 15, 504-14. DOI ScienceOn |
33 | Kwon MJ, Shin YK (2013). Regulation of ovarian cancer stem cells or tumor-initiating cells. Int J Mol Sci, 14, 6624-48. DOI |
34 | Garofalo M, Croce CM (2011). microRNAs: Master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol, 51, 25-43. DOI |
35 | Elton TS, Selemon H, Elton SM, Parinandi NL (2012). Regulation of the MIR155 host gene in physiological and pathological processes. Gene, 532, 1-12 |
36 | Adhikari AS, Agarwal N, Iwakuma T (2011). Metastatic potential of tumor-initiating cells in solid tumors. Front Biosci, 16, 1927-38. DOI |
37 | Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. DOI ScienceOn |
38 | Garzon R, Calin GA, Croce CM (2009). MicroRNAs in Cancer. Annu Rev Med, 60, 167-79. DOI ScienceOn |
39 | Georgantas RW, Hildreth R, Morisot S, et al (2007). CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA, 104, 2750-5. DOI ScienceOn |
40 | Greither T, Grochola LF, Udelnow A, et al (2010). Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer, 126, 73-80. DOI ScienceOn |
41 | Guo W, Lasky JL, Wu H (2006). Cancer stem cells. Pediatr Res, 59, 59-64. DOI |
42 | Habbe N, Koorstra JB, Mendell JT, et al (2009). MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther, 8, 340-6. DOI ScienceOn |
43 | Chen CZ (2005). MicroRNAs as oncogenes and tumor suppressors. N Engl J Med, 353, 1768-71. DOI ScienceOn |
44 | Hatfield S, Ruohola-Baker H (2008). microRNA and stem cell function. Cell Tissue Res, 331, 57-66. DOI ScienceOn |
45 | Bertolini G, Roz L, Perego P, et al (2009). Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA, 106, 16281-6. DOI ScienceOn |
46 | Bushati N, Cohen SM (2007). microRNA functions. Annu Rev Cell Dev Biol, 23, 175-205. DOI ScienceOn |
47 | Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 65, 10946-51. DOI ScienceOn |
48 | Donnem T, Eklo K, Berg T, et al (2011). Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization. J Transl Med, 9, 6. DOI ScienceOn |
49 | Ryu JK, Hong SM, Karikari CA, et al (2010). Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology, 10, 66-73. DOI ScienceOn |
50 | Zandberga E, Kozirovskis V, Abols A, et al (2013). Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer, 52, 356-69. DOI |
51 | Faraoni I, Antonetti FR, Cardone J, Bonmassar E (2009). miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta, 1792, 497-505. DOI |
![]() |